Individuals affected with the Gorlin syndrome inherit a germ-line mutation of the patched (Ptc1) developmental gene and, analogously to Ptc1 heterozygous mice, show an increased susceptibility to spontaneous tumor development. Human and mouse Ptc1 heterozygotes (Ptc1 +/7 ) are also hypersensitive to ionizing radiation (IR)-induced tumorigenesis in terms of basal cell carcinoma (BCC) induction. We have analysed the involvement of Ptc1 in the tumorigenic response to a single dose of 3 Gy X-rays in neonatal and adult Ptc1 heterozygous and wild type mice. We report that irradiation dramatically increased the incidence of medulloblastoma development (51%) over the spontaneous rate (7%) in neonatal but not adult Ptc1 heterozygotes, indicating that medulloblastoma induction by IR is subjected to temporal restriction. Analysis of Ptc1 allele status in the tumors revealed loss of the wild type allele in 17 of 18 medulloblastomas from irradiated mice and in two of three spontaneous medulloblastomas. To our knowledge, irradiated newborn Ptc1 +/7 heterozygous mice constitute the first mouse model of IR-induced medulloblastoma tumorigenesis, providing a useful tool to elucidate the molecular basis of medulloblastoma development.
Individuals affected with the Gorlin syndrome inherit a germ-line mutation of the patched (Ptc1) developmental gene and, analogously to Ptc1 heterozygous mice, show an increased susceptibility to spontaneous tumor development. Human and mouse Ptc1 heterozygotes (Ptc1 +/7 ) are also hypersensitive to ionizing radiation (IR)-induced tumorigenesis in terms of basal cell carcinoma (BCC) induction. We have analysed the involvement of Ptc1 in the tumorigenic response to a single dose of 3 Gy X-rays in neonatal and adult Ptc1 heterozygous and wild type mice. We report that irradiation dramatically increased the incidence of medulloblastoma development (51%) over the spontaneous rate (7%) in neonatal but not adult Ptc1 heterozygotes, indicating that medulloblastoma induction by IR is subjected to temporal restriction. Analysis of Ptc1 allele status in the tumors revealed loss of the wild type allele in 17 of 18 medulloblastomas from irradiated mice and in two of three spontaneous medulloblastomas. To our knowledge, irradiated newborn Ptc1 +/7 heterozygous mice constitute the first mouse model of IR-induced medulloblastoma tumorigenesis, providing a useful tool to elucidate the molecular basis of medulloblastoma development. Oncogene (2002 Oncogene ( ) 21, 7580 -7584. doi:10.1038 Keywords: patched-knockout mice; X-rays; medulloblastoma; LOH The sonic hedgehog (shh) signaling pathway has been implicated in the etiology of central nervous system tumors (CNS) (Corey et al., 1997) . However, the mechanisms underlying hedgehog-mediated tumorigenesis are poorly understood. Individuals affected with Gorlin syndrome, an autosomal dominant disease, carry a germ line mutation in the patched (Ptc1) gene (Hahn et al., 1996) . This syndrome is characterized by a variety of clinical problems, such as increased body size, developmental abnormalities of the skeleton and a predisposition to benign and malignant tumors (Gorlin, 1987) . Tumors associated with the syndrome include basal cell carcinomas (BCCs) of the skin, rhabdomyosarcomas (Miller and Weinstock, 1994; Pappo et al., 1997) , and medulloblastomas (Lacombe et al., 1990) . The latter represent the predominant cerebellar tumors arising in young children, with a mortality rate of 50% (Novakovic, 1994) . Lack of an appropriate animal model has hampered progress in understanding the mechanisms underlying medulloblastoma development. Recently, two independent mouse strains have been generated in which the Ptc1 gene is inactivated through targeted disruption (Goodrich et al., 1997; Hahn et al., 1998) . Heterozygous Ptc1 knockout (Ptc1 +/7 ) mice display the typical symptoms of the Gorlin syndrome, including an increased propensity to develop tumors in the brain and soft tissues. Histological and marker expression analysis of the brain tumors has revealed that they closely resemble human medulloblastoma (Wetmore et al., 2000) .
The frequency of ionizing radiation (IR)-induced developmental defects was found to be 4.1 times higher in Ptc1 heterozygous mice than in wild type littermates (Hahn et al., 1998) . In addition, analogously to Gorlin syndrome patients subjected to radiation therapy for medulloblastoma, Ptc1 +/7 mice have been reported to develop a high incidence of BCC-like tumors in response to ultraviolet or ionizing radiation exposure (Aszterbaum et al., 1999) . These data suggest that Ptc1 heterozygotes show an increased sensitivity to IR and that, along with its patterning role, Ptc1 is involved in the response to IR.
To test the role of Ptc1 in radiation induced tumorigenesis we irradiated mice lacking one Ptc1 allele, derived by gene targeting of 129/SV ES cells and maintained on a CD1 background (Hahn et al., 1998) . Since Ptc1 is a developmental gene, and the shh/Ptc1/smo-signaling pathway has been implicated in a plethora of processes in the developing embryos including CNS development (Martı`and Bovolenta, 2002) , we assumed that the age at irradiation could be an important determinant; thus, we performed irradiation of both newborn and adult mice. Mice of both sexes were exposed to a single dose of 3 Gy Xrays given whole-body at 4 days or 3 months of age.
The tumor-free survival of Ptc1 +/7 and wild type mice irradiated at 3 months of age was comparable to that of the non-irradiated controls. As shown in Figure  1 , mortality occurred predominantly in Ptc1 +/7 groups irrespective of irradiation, during the 72 weeks of observation. Tumor development was also independent from irradiation, the tumor incidence being 50% in unirradiated versus 51% in irradiated Ptc1 +/7 mice ( Table 1) . The tumor spectrum observed shows that both irradiated and unirradiated Ptc1 +/7 mice developed similar types of tumors with comparable incidences. Exceptions are represented by BCCs, arising exclusively in the irradiated Ptc1 +/7 mice (object of a separate study). No medulloblastomas were found in irradiated Ptc1 +/7 mice, reflecting the selection operated by enroling only healthy animals at the time of irradiation. Soft tissue sarcomas represented the predominant tumor type in Ptc1 +/7 mice, with incidences of 40% in unirradiated and 37% in irradiated mice at 72 weeks. The incidence of thymic lymphoma in irradiated mice was 2.4% in heterozygous Ptc1 +/7 and 7% in wild type mice. Only one irradiated Ptc1 +/7 mouse developed two independent tumors (sarcoma and thymic lymphoma).
We next investigated the effects of irradiation at 4 days of age. In contrast to the previous experiment, a striking difference in the tumor-free survival was observed in irradiated compared to unirradiated heterozygous Ptc1 +/7 mice (Figure 2 ). At 28 weeks of age 80% of the irradiated heterozygous Ptc1 +/7 mice had died compared to only 10% of unirradiated heterozygous Ptc1 +/7 mice. By 38 weeks 67% of the irradiated wild type mice and only 10% of the irradiated heterozygous Ptc1 +/7 had survived. The tumor spectrum in this group is reported in mice. Moreover, a significantly higher percentage (74.5%) of irradiated Ptc1 +/7 developed tumors compared to 30.4% of irradiated wild type mice, indicating that germ-line inactivation of one copy of Ptc1 confers an increased susceptibility to radiationinduced oncogenesis. The major cause of death among irradiated heterozygous Ptc1 +/7 mice irradiated at 4 days was medulloblastoma (51%), whereas that of wild type mice was thymic lymphoma (30.4%). Malignant lymphoma induction following irradiation did not show differences with respect to the Ptc1 genotype, being 25% in Ptc1 +/7 and 30% in Ptc1 +/+ . Multiple Figure 1 Mortality of Ptc1 +/7 and wild type mice irradiated at 3 months of age. Forty-one Ptc1 +/7 and 43 wild type littermates were irradiated with a single dose of 3 Gy X-rays (at a dose rate of 0.54 Gy/min). Thirty Ptc1 +/7 and 22 wild type littermates were left untreated and observed for 72 weeks. No decrease in per cent survival of Ptc1 +/7 irradiated compared to the Ptc1 +/7 control mice was observed. Mice of both sexes were exposed to wholebody X-ray-irradiation (HVL=1.6 mmCu) using a Gilardoni CHF 320 G X-ray generator (Gilardoni S.p.A., Mandello del Lario, Lecco, Italy) operated at 250 kVp, 15 mA, with filters of 2.0 mm Al and 0.5 mm Cu Figure 2 Mortality of Ptc1 +/7 and wild type mice irradiated at 4 days of age. Fifty-one Ptc1 +/7 and 46 wild type littermates were exposed to a single dose of 3 Gy X-rays (dose rate of 0.89 Gy/min). Twenty-six Ptc1 +/7 and 31 wild type littermates were left untreated and observed for 38 weeks. Irradiated Ptc1 +/7 mice show a high mortality compared to Ptc1 +/7 control and irradiated wild type mice. There were no increases in acute mortality associated with the radiation treatments. For irradiation conditions refer to Figure 1 legend *Two independent tumors (thymic lymphoma and sarcoma) were observed in one mouse
Ptc1 loss in mouse X-ray-induced medulloblastoma S Pazzaglia et al tumors (thymic lymphoma and medulloblastoma) were observed in five (10%) of the Ptc1 +/7 irradiated mice. In Ptc1 +/7 mice on the CD1 background we observed a spontaneous medulloblastoma incidence of 7.7%, as compared to an incidence of 14% observed on the C57BL/6 background (Wetmore et al., 2000) . Irradiation of newborn Ptc1 +/7 mice with a single dose of 3 Gy X-rays dramatically increased the incidence of medulloblastoma (51%) 6.6 times over the spontaneous incidence (Figure 3) . No medulloblastoma was observed in control or irradiated wild type mice. Both radiation-induced and spontaneous medulloblastomas arose in the same anatomical location (posterior fossa) and exhibited the same histology.
Our data show that medulloblastoma induction by IR is subjected to temporal restriction. The ability of IR to induce medulloblastoma only in newborn, but not in adult heterozygous Ptc1 +/7 mice may indicate that at the time of irradiation target cells are still in a receptive phase for radiation induced stochastic effects that can result in enhanced tumorigenesis. Medulloblastomas are thought to originate from granule precursor cells (GPCs) (Rowitch et al., 1999 ) that undergo rapid expansion in the external germinal layer of the cerebellum during the first 2 weeks of post-natal life. In mice, GPCs differentiate and migrate to their mature position in the internal granule layer by the third week of postnatal development (Goldowitz and Hamre, 1998) . Although the proliferation potential of the granule cells retained by the newborn mice might be essential for medulloblastoma induction by IR, our data show that it is not sufficient. In fact, no medulloblastomas were observed after neonatal irradiation of wild type mice, while enhanced brain tumorigenesis was observed after neonatal irradiation of heterozygous Ptc1 +/7 mice. Altogether, our results suggest that IR-induced formation of medulloblastoma is dependent on haploinsufficiency of Ptc1.
It is unclear how Ptc1 haploinsufficiency can predispose to spontaneous and radiation-induced medulloblastoma development. Recently, an interaction between phosphorylated cyclin B1 and Ptc1 was demonstrated, providing a link between Ptc1 signalling and cell cycle progression (Barnes et al., 2001) . According to this model, Ptc1 does not allow cyclin B1 to localize into the nucleus, preventing mitotic progression. Thus, in heterozygous Ptc1 mice the reduced levels of Ptc1 protein could result in defective regulation of the G2/M checkpoint. Exposure to ionizing radiation blocks cell cycle progression at the G2/M boundary (G2 delay), to provide time to repair the DNA damage before chromosome segregation. Defects at the G2/M checkpoint could result in DNAdamaged cells entering into mitosis before repair occurred. This hypothesis is also supported by the results of a very recent study performed in hemizygous Ptc1 mice lacking p53 (Wetmore et al., 2001) , showing a high incidence (495%) of medulloblastomas, and closely resembling our data obtained by neonatal irradiation of Ptc1 +/7 mice. The p53 tumor suppressor has also been shown to prevent G2/M transition by decreasing intracellular levels of cyclin B1 (Innocente et al., 1999) .
In the present study we found that spontaneous medulloblastoma develop in only 7% of Ptc1 +/7 mice, whereas a high rate of medulloblastoma induction (450%) was observed after X-ray irradiation of 4 days old Ptc1 +/7 mice. These data indicate that haploinsufficiency alone is not sufficient to induce tumor formation and that additional genetic lesions are required for tumorigenesis. Although it has been suggested that loss of both Ptc1 alleles is a critical step in initiating formation of BCCs Unden et al., 1996; Wicking et al., 1997 ) the mechanism of medulloblastoma formation is still controversial. Two recent studies on Ptc1 heterozygous mice (on a 129Sv or C57BL/6 background) reported that haploinsufficiency of Ptc1 is sufficient to promote tumorigenesis in the CNS (Zurawel et al., 2000; Wetmore et al., 2000) . However, the importance of the complete inactivation of Ptc1 emerges from studies Figure 3 Spontaneous and radiation-induced medulloblastoma incidences in Ptc1 +/7 mice. More than 50% of the neonatally irradiated Ptc1 +/7 mice developed medulloblastomas compared with 7.7% of Ptc1 +/7 unirradiated mice Ptc1 loss in mouse X-ray-induced medulloblastoma S Pazzaglia et al reporting a correlation between the presence of Ptc1 point mutation and LOH for 9q22 in medulloblastoma (Xie et al., 1997; Zurawel et al., 1997) . On the other hand, when investigating medulloblastoma from Gorlin syndrome patients the second Ptc1 allele was found to be mutated in only one case of three examined (Cowan et al., 1997) . In order to clarify the mechanisms of medulloblastoma development, we have investigated the status of the normal Ptc1 allele in spontaneous and radiationinduced medulloblastomas. Figure 4 shows a representative agarose gel, demonstrating loss of the wild type Ptc1 allele in medulloblastomas isolated from six irradiated and one control Ptc1 +/7 heterozygotes. Allelic imbalance analysis revealed LOH of the wild type Ptc1 locus in 94% (17/18) of medulloblastomas isolated from irradiated Ptc1 +/7 mice. This finding supports a causative role for loss of the wild type Ptc1 allele in IR-induced medulloblastoma tumorigenesis. We also detected loss of wild type Ptc1 in two of three of spontaneous medulloblastomas from Ptc1 +/7 mice, but the small number of samples examined did not allow drawing of definitive conclusions on the involvement of the Ptc1 wild type loss in spontaneous medulloblastoma formation.
In summary, our data show that medulloblastoma formation in heterozygous Ptc1 mice is induced by IR and involves loss of both Ptc1 alleles. Furthermore, our data demonstrate that the increase of medulloblastoma frequency only occurs in irradiated neonatal, but not in irradiated adult heterozygous Ptc1 +/7 mice. The tumorigenic window observed in this study might reflect a time-limited ability of the GPCs to proliferate. We suggest that the functional consequence of Ptc1 haploinsufficiency, predisposing to medulloblastoma development, is the result of a defect in the radiation-sensitive G2/M checkpoint.
The ability to experimentally induce medulloblastoma at a very high rate (50%) provides a useful model to study its pathogenesis and will help to gain fundamental insights into the induction and progression of this brain tumor. It will furthermore be a useful model for development of therapies against this very malignant childhood neoplasia. Figure 4 Representative loss of the wild type Ptc1 allele in medulloblastomas arising in Ptc1 +/7 mice. Brain tumor cells and non-cancerous tissues were isolated by microdissection from different areas of the same histological sample. Microdissection was conducted at the microscope using a small scalpel. DNA was extracted using the NucleoSpin Tissue kit (Macherrey-Nagel, Duren, Germany) and resuspended in 40 ml of deionized water. Amplification of the Ptc1 wild type and targeted alleles followed the method of Hahn et al. (1998) . Data were inspected visually after scanning the ethidium bromide gels on an electrophoresis documentation and analysis system (EDAS 290). Gels were analysed for mass and molecular weight using the 1D automatic lane and band finder (Image Analysis Software, Kodak). Allele ratios were determined by dividing the mass of the mutated allele (Mu) by the mass of the wild type allele (Wt). Q AI (Tumor allele ratio/ Normal allele ratio) was determined by dividing the allelic ratio in the tumor sample by the ratio in the corresponding normal control. Mu and Wt Ptc1 alleles were always equally represented in microdissected normal brain tissues (N) with allelic ratio values (Mu/Wt) of approximately 1.0 (mean=1.35; SD=0.23). Q AI could have any value between zero and infinity, with 0 being 100% loss of Mu allele, and infinity being 100% loss of Wt allele. Q AI values 50.33 or 43 were considered indicative of allelic imbalance (AI). In all the medulloblastomas showing a Q AI 43 we identified a bona fide LOH profile indicative of loss of the Wt allele. The limit value corresponds to a maximum of 33% normal tissue contamination. LOH was confirmed but at least two independent amplification reactions. Mu, mutant Ptc1 allele; Wt, wild type Ptc1 allele; T, DNA derived from tumor tissue; N, DNA derived from normal tissue; R, radiation-induced tumors; S, spontaneous tumors; M, marker (Phix Hae III fragments-LT1bp). N allele ratio values (Mu mass/Wt mass) ranged within 1.03 and 1.27. Q AI (T allele ratio/N allele ratio) were the following: S1, R28, R20=?; R11=6.5; R1=6.15; R2=4.32; R38=3.03. These tumors were all scored as showing LOH
